Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $195,006 - $216,978
933 Added 38.65%
3,347 $731,000
Q4 2023

Feb 08, 2024

BUY
$197.69 - $227.29 $117,625 - $135,237
595 Added 32.71%
2,414 $548,000
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $11,459 - $12,636
57 Added 3.23%
1,819 $365,000
Q2 2023

Aug 09, 2023

BUY
$211.93 - $241.33 $12,927 - $14,721
61 Added 3.59%
1,762 $425,000
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $31,144 - $37,643
146 Added 9.39%
1,701 $390,000
Q4 2022

Feb 06, 2023

SELL
$203.72 - $248.97 $823,436 - $1.01 Million
-4,042 Reduced 72.22%
1,555 $366,000
Q3 2022

Nov 01, 2022

BUY
$204.81 - $262.19 $33,384 - $42,736
163 Added 3.0%
5,597 $1.15 Million
Q2 2022

Jul 22, 2022

BUY
$213.86 - $277.87 $29,298 - $38,068
137 Added 2.59%
5,434 $1.27 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $119,517 - $137,162
460 Added 9.51%
5,297 $1.4 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $103,479 - $119,714
381 Added 8.55%
4,837 $1.52 Million
Q3 2021

Nov 08, 2021

BUY
$274.82 - $308.34 $167,640 - $188,087
610 Added 15.86%
4,456 $1.25 Million
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $968,692 - $1.07 Million
3,846 New
3,846 $1.06 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Arjuna Capital Portfolio

Follow Arjuna Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.